Aethlon Medical logo
Aethlon Medical AEMD
$ 0.57 2.87%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Aethlon Medical Financial Ratios 2011-2024 | AEMD

Annual Financial Ratios Aethlon Medical

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.1 -0.1 -0.6 -1.5 -0.8 -2.2 -2.9 -2.4 -7.4 -6.7 -3.1 -3.4 -1.4 -1.1

P/S

- 1.5 21.1 18.3 7.4 60.0 110.3 44.2 40.5 59.8 25.1 13.3 8.2 -

EPS

-4.9 -5.9 -0.7 -0.7 -1.9 -5.1 -0.1 -0.9 -0.7 -1.2 -3.4 -0.0 -0.1 -0.1

EV (Enterprise Value)

-1.5 M -11.2 M -8.45 M 3.6 M -3.71 M 11.8 M 10.8 M 16.9 M 34.9 M 45.5 M 55.9 M 25.9 M 21.2 M 12.8 M

EBITDA per Share

-4.89 -5.68 -0.7 -0.649 -1.73 -4.94 -5.84 -11.7 -8.82 -10.6 -11.7 -17.9 -22.8 -48.9

EV/EBITDA

-0.5 0.8 -1.8 -2.2 -2.7 -7.9 -11.3 -13.9 -5.3 -4.7 -1.9

PEG

-0.0 -0.0 0.02 0.05 -0.01 -0.09 -0.06 0.06 -0.16 -0.1 0.02 -0.05 0.03 0.02

P/B

0.3 0.1 0.4 1.3 0.5 6.0 2.7 29.1 23.9 70.0 -2.8 -1.8 -1.2 -1.0

P/CF

-0.1 -0.1 -0.6 -1.8 -0.9 -3.2 -4.2 -4.9 -8.3 -9.0 -18.2 -7.8 -6.1 -3.2

ROE %

-211.71 -79.86 -60.80 -83.63 -68.70 -269.44 -94.14 -1222.03 -324.31 -1043.50 90.68 53.50 87.26 95.58

ROA %

-148.05 -68.71 -53.64 -73.92 -61.36 -150.25 -77.25 -421.47 -190.57 -492.34 -787.99 -984.92 -967.14 -1006.92

ROCE %

-219.14 -78.99 -60.82 -83.68 -63.63 -260.93 -70.28 -547.13 -215.99 -495.02 21.90 39.10 33.50 76.26

Current Ratio

3.3 7.2 8.0 7.8 9.4 2.2 15.1 2.6 4.6 2.1 0.1 0.0 0.1 0.1

DSO

- 40.7 171.9 98.5 116.1 - 182.5 - 82.1 92.6 21.4 62.0 107.4 -

DIO

- - - - - - - - - - - - - -

DPO

42.4 38.3 33.0 32.9 - - - - - - - - - -

Operating Cycle

- 40.7 171.9 98.5 - - - - - - - - - -

Cash Conversion Cycle

-42.4 2.4 138.8 65.6 - - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Aethlon Medical

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.2 -0.34 - -1.37 -1.22 -1.35 - -1.24 -1.84 -0.19 - -0.16 -0.46 -0.29 - -0.2 -0.2 -0.15 -0.15 -0.28 -0.28 -1.29 -0.11 -1.67 -0.11 -0.08 - -0.08 -0.14 -0.21 - -0.15 -0.72 -0.57 - -0.16 -0.5 -0.34 - -0.26 -1.12 -0.92 - -0.01 -0.03 -0.02 - - -0.01 -0.02 - -0.01 -0.04 -0.03 -

EBITDA per Share

- -0.34 - - - -1.36 - -1.24 -1.69 -0.19 - -0.16 -0.45 -0.29 - -0.2 -0.2 -0.15 -0.15 -0.3 -0.3 -1.29 -0.08 -1.63 -0.11 -0.07 - -0.08 -0.14 -0.13 - -0.16 -0.59 -0.43 - -0.14 -0.45 -0.31 - -0.18 -0.01 -0.01 - -0.01 -0.01 -0.01 - -0.01 -0.02 -0.01 - - -0.02 -0.02 -

ROE %

-167.23 -150.00 -99.98 -116.48 -87.43 -77.19 -55.13 -67.42 -63.21 -73.00 -49.73 -70.84 -79.67 -91.76 -73.72 -88.71 -88.43 -596.87 -734.22 -804.44 -844.75 -344.03 -221.83 -162.48 -127.20 -1276.14 -1010.73 -2628.62 -4220.64 5242.88 5636.10 5591.83 7165.45 -1193.27 -184.62 -312.02 -395.15 -129.33 167.52 188.16 336.20 214.25 113.01 108.72 83.79 57.93 49.87 59.28 72.98 104.90 111.75 9.41 57.01 45.33 -

ROA %

-120.67 -112.60 -77.64 -91.39 -71.93 -64.79 -47.23 -58.76 -56.53 -67.78 -47.41 -66.69 -74.45 -91.06 -75.43 -84.01 -82.23 -55.35 -176.61 -238.48 -261.64 -284.80 -178.21 -128.88 -109.34 -182.46 -496.64 -649.35 -780.92 -1255.08 -1040.74 -1074.62 -955.80 -444.89 -151.21 -200.33 -215.57 -681.15 -985.22 -1091.19 -1148.03 -2036.32 -3407.95 -3305.71 -3097.51 -2114.28 -641.88 -705.52 -871.41 -1542.23 -2125.82 -63.64 -1118.49 -943.69 -

ROCE %

- - - -16.49 -32.98 -51.43 -54.42 -66.71 -62.52 -73.04 -57.88 -79.00 -87.84 -76.70 -50.53 -65.52 -66.67 -636.42 -773.51 -823.11 -860.48 -320.47 -197.63 -157.82 -122.93 -1210.84 -1026.18 -2684.07 -4317.20 3611.04 4359.82 4320.39 5938.85 -938.45 -167.61 -240.99 -274.94 -72.59 110.36 121.76 206.55 108.19 42.34 55.14 56.53 69.29 66.36 71.94 64.74 68.13 69.76 5.59 35.60 28.57 -

Current Ratio

3.1 4.2 3.3 3.7 5.1 5.9 7.2 6.0 7.2 7.8 8.0 16.1 17.4 - 7.8 10.2 8.5 12.1 14.8 5.3 3.7 0.7 1.6 2.8 3.9 3.9 5.6 5.0 1.0 0.3 1.5 1.0 0.9 1.4 2.5 4.1 5.7 6.7 1.9 1.7 0.2 0.2 0.1 - - - 0.1 - - - - - - - -

DSO

- - - - - - - - - - - 703.5 42.9 48.6 - 16.6 23.3 - - 22.8 - - - - - - - - - - - - 22.5 1963.5 - - - - - 373.8 25.7 94.5 - 158.6 11.0 11.3 - - - 29.6 - 8.7 - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

66.2 67.1 - 32.8 58.6 51.9 - 25.6 32.8 41.6 - 22.3 8.1 14.6 - 14.6 16.9 43.7 64.0 102.7 96.9 31.2 15.2 6.3 9.2 18.2 - 33.5 40.8 55.1 - 48.6 12.5 13.2 - 32.2 16.2 31.0 - 74.6 33.3 46.0 - 150.1 56.0 94.9 - 114.2 35.6 50.6 - 97.7 21.8 27.4 -

Operating Cycle

- - - - - - - - - - - 703.5 42.9 48.6 - 16.6 23.3 - - 22.8 - - - - - - - - - - - - 22.5 1963.5 - - - - - 373.8 25.7 94.5 - 158.6 11.0 11.3 - - - 29.6 - 8.7 - - -

Cash Conversion Cycle

-66.2 -67.1 - -32.8 -58.6 -51.9 - -25.6 -32.8 -41.6 - 681.2 34.8 34.0 - 2.0 6.4 -43.7 -64.0 -79.8 -96.9 -31.2 -15.2 -6.3 -9.2 -18.2 - -33.5 -40.8 -55.1 - -48.6 10.0 1950.3 - -32.2 -16.2 -31.0 - 299.2 -7.6 48.5 - 8.4 -45.0 -83.5 - -114.2 -35.6 -21.0 - -89.0 -21.8 -27.4 -

All numbers in USD currency